FDAReview.org

As Insulin Prices Rise, Diabetics Turn to Black Markets

Raymond March - July 9, 2019

San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke

July 3, 2019

Right-to-Try Legislation Helps Patient Battling Bone Cancer

June 24, 2019

FDA Approves $2 Million Drug. Blame the Price on Excessive Regulation.

May 30, 2019

What's New

FDA To Stop Regulating the Amount of Cherries in Frozen Cherry...

Raymond March - May 15, 2019

Political Rhetoric Against Right-to-Try Laws Continues, Undermining Support for Medical Treatments...

Raymond March - May 7, 2019

FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression

Raymond March - March 28, 2019

Generic Insulin Now Available After Nearly One Hundred Years of Regulatory...

Raymond March - March 25, 2019

FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?

Raymond March - March 14, 2019

FDA Panel Backs Ketamine-Based Treatment for Depression

Raymond March - March 1, 2019

Let Competition, Not Politicians, Bring Insulin Prices Down

Raymond March - February 20, 2019

Right-to-try Laws Help Patient with Terminal Brain Cancer

Raymond March - February 1, 2019

FDA Approves Record Number of Generic Drugs in 2018

Raymond March - January 9, 2019

Teen Vaping Is Bad, but the Alternative Is Worse

January 8, 2019

Can the FDA Prevent Teens from Vaping?

January 4, 2019

Deregulation Is the Only Cure for High Drug Prices

January 3, 2019

FDA Vaping Regulations Will Do More Harm than Good

November 30, 2018